Metformin is a medication commonly prescribed for type two diabetics. Metformin is also sold as Glucophage, Fortamet, and Glumetza. A recent study in the scientific research journal of the Brazilian medical association found a high prevalence of vitamin B12 deficiency in Metformin treated diabetic patients.
Vitamin B12 is a water soluble vitamin that is naturally present in foods such as fish, shellfish, poultry, milk, eggs and meat. Vitamin B12 is necessary proper function of your nervous system, the manufacture of red blood cells as well as to make DNA. Vitamin B12 is also associated with regulating Homocysteine levels which is associated with heart disease.
Symptoms associated with vitamin B12 deficiency include:
- feeling tired and weak
- tingling in the hands and feet
- trouble with balance and walking
- mood changes including depression
- weight loss.
- soreness of the tongue
- bleeding gums
- frequent bruising
- paleness of the skin.
Vitamin B12 levels are typically evaluated by serum or plasma analysis. This type of testing can be performed at any of your standard laboratories such as Quest Diagnostics and as such are readily available to patients in the United States .
Ten to thirty percent of those over 50 years of age suffer from a condition called atrophic gastritis. In atrophic gastritis, there are reduced levels of hydrochloric acid produced by the stomach. The consequence of this low hydrochloric acid production is diminished absorption of vitamin B12. Thus, if you are elderly and a diabetic taking metformin, the chances of your having a vitamin B12 deficiency increase.
Vegetarians, who by definition do not eat animal proteins, and are the most prevalent source of vitamin B12, and those with digestive disorders such as crohn's disease, also need to beware of possible B12 deficiency. Once again, this is especially true if coupled with being a diabetic was taking metformin.
If you're a diabetic and taking Metformin and feel that several of the signs and symptoms listed above pertain to you, contact your physician for a vitamin B12 analysis. Many physicians are not aware of the nutritional consequences of the medication they prescribe and therefore a visit to a functional medicine practitioner may be in order.
Whole Foods Recalls Cheese Over Listeria Fears
No illness or infections have been reported in connection with the cheese.
California gives Volkswagen November 20 deadline for technical fix in diesel scandal
California has given carmaker Volkswagen until November 20 to come up with a plan to fix the diesel cars affected by its rigging of emissions tests, a spokesman for the California Air Resources Board (CARB) said on Friday. Volkswagen has said up to 11 million diesel vehicles worldwide need to be refitted because they could carry software designed to manipulate emissions tests. The CARB spokesman said the deadline represents 45 business days from an in-use compliance letter sent to Volkswagen dated Sept. 18.
FDA expands lung cancer approval for Bristol-Myers' drug
The U.S. Food and Drug Administration on Friday expanded its approval of Bristol-Myers Squibb Co's immunotherapy drug Opdivo for patients with an additional form of advanced lung cancer. The agency said Opdivo may now be used in patients with non-squamous non-small cell lung cancer (NSCLC) whose disease has progressed during or after platinum-based chemotherapy. Opdivo, known chemically as nivolumab, was first approved to treat advanced melanoma, the deadliest form of skin cancer, and later for squamous non-small cell lung cancer.
Many babies exposed to unnecessary pain in research
By Frederik Joelving (Reuters Health) - Babies often suffer unnecessary pain in clinical studies, potentially breaching international standards for ethical research, according to a new review of the medical literature. “We are urging parents and ethics review boards to refuse studies that do not provide acceptable analgesia to all babies enrolled in studies, if such pain relief exists,” they wrote in Acta Paediatrica, a medical journal, online September 21. “In addition we are calling on medical journals to refuse to publish studies that deny pain relief to control infants undergoing painful procedures.” Research shows babies experience pain more powerfully than adults, according to Celeste Johnston, one of the report’s two authors and an emeritus professor at the Ingram School of Nursing at McGill University in Montreal, Canada.
Health groups slam Ukraine for slow polio response
Global health groups accused Ukraine on Friday of being critically late and ineffective in responding to Europe's first polio outbreak since 2010. The World Health Organization (WHO) confirmed in late August that two Ukrainian children had been crippled by the virus in the former Soviet state's southwestern Zakarpattya region. Both the WHO and the Kiev government blamed the cases -- the first in Ukraine since 1996 -- on low vaccination coverage throughout the war-torn state.
Boston Scientific mesh verdict slashed to $10 million
By Jessica Dye NEW YORK (Reuters) - A Delaware judge on Friday said Boston Scientific should only have to pay $10 million to a woman originally awarded $100 million by a jury who found she was injured by transvaginal mesh, a device that is the subject of thousands of lawsuits. Judge Mary Johnston in New Castle County, Delaware, said that the damages awarded to plaintiff Deborah Barba in May – the largest ever in a trial involving transvaginal mesh - were “grossly disproportionate to the injuries suffered and shock the court’s conscience and sense of justice.” But Johnston denied Boston Scientific's bid to set aside the verdict altogether and order a new trial. While the jury had properly decided the company's liability, Johnston wrote in her ruling that the jury’s award was too high, particularly in comparison with the other mesh trials, in which punitive damages awards spanned from $1.75 million to $7.76 million.
Presidential candidate Sanders opposes Obama's FDA nominee
U.S. Senator Bernie Sanders, who is seeking the Democratic presidential nomination, said on Friday he will vote against Dr. Robert Califf as the next commissioner of the Food and Drug Administration, citing the nominee's close ties to the pharmaceutical industry. "Instead of listening to the demands of the pharmaceutical industry and their 1,400 lobbyists, it is about time that the FDA and Congress started listening to the overwhelming majority of the American people, who believe that medicine is too expensive," Sanders said in a news release announcing his intention to vote against Califf. President Barack Obama nominated Califf, a prominent cardiologist and researcher at Duke University who joined the FDA in January as a deputy commissioner, on Sept. 15.
Court battle over Amish girl's cancer treatment ends
An Ohio judge on Friday formally ended a court effort to force chemotherapy on an Amish girl whose parents had defied a hospital over her treatment for leukemia, according to a ruling released on Friday. Medina County Probate and Juvenile Judge Kevin Dunn terminated the medical guardianship for the girl, ending a legal battle over the limits on parents' rights to make medical decisions. A court-appointed medical guardian had already given up on forcing the girl to resume chemotherapy after her family left the country for a while in 2013 to pursue alternative treatments that the family said improved the girl's condition.
Eye-tracking devices may help ICU patients communicate
By Lisa Rapaport (Reuters Health) - Eye-tracking devices might help some patients communicate even when mechanical ventilators make it impossible for them to speak, a small pilot project suggests. Researchers offered eye-trackers to 12 patients on ventilators in intensive care units (ICUs) at the Johns Hopkins Hospital in Baltimore, Maryland, during 2013 and 2014. All of the participants were cognitively capable of communication and able to convey comprehension by blinking, nodding their head or some other motion.
Support rising for outdoor smoking bans in U.S., Canada
By Janice Neumann (Reuters Health) - A growing number of people in the U.S. and Canada support smoke-free laws for outdoor venues, especially where children congregate or at building entrances, according to a new review of public surveys. Based on 89 surveys in both countries between 1993 and 2014, researchers say the growth of support for smoking restrictions, even among smokers, shows that outdoor smoking bans can achieve majority support. “This and other studies have found that it looks like people may become more favorable towards these regulations once they’re put in place and they get used to them,” said Deborah Ossip, president-elect of the Society for Research on Nicotine and Tobacco, who was not involved in the study.